Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Clinical trial NCT00289757 · COMPLETED
Trial details
- NCT number
- NCT00289757
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2013-03-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.